Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | F2 | P00734 | 2/20 | 0.46 |
| ▸ | CMA1 | P23946 | 1/20 | 0.43 |
| ▸ | ACE | P12821 | 12/20 | 0.43 |
| ▸ | ACE2 | Q9BYF1 | 6/20 | 0.43 |
| ▸ | ELANE | P08246 | 2/20 | 0.40 |
| ▸ | CTSG | P08311 | 1/20 | 0.40 |
| ▸ | TMPRSS11D | O60235 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9012113 | 1.00 | F2 (0.46) | F2CMA1ACEACE2ELANE | |
| SCHEMBL9012544 | 0.90 | F2 (0.45) | F2CMA1ACE | |
| SCHEMBL9012551 | 0.90 | F2 (0.45) | F2CMA1ACE | |
| SCHEMBL9011941 | 0.90 | F2 (0.51) | F2CMA1ACEACE2TMPRSS11D | |
| SCHEMBL9011943 | 0.90 | F2 (0.51) | F2CMA1ACEACE2TMPRSS11D | |
| SCHEMBL9011998 | 0.87 | F2 (0.50) | F2CMA1ACETMPRSS11D | |
| SCHEMBL9012003 | 0.87 | F2 (0.50) | F2CMA1ACETMPRSS11D | |
| SCHEMBL9012557 | 0.87 | F2 (0.46) | F2CMA1ELANECTSGTMPRSS11D | |
| SCHEMBL9012549 | 0.87 | F2 (0.46) | F2CMA1ELANECTSGTMPRSS11D | |
| SCHEMBL9012328 | 0.85 | F2 (0.41) | F2CMA1ACETMPRSS11D |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0743320-A2 | Acyl guanidine and amidine prodrugs | BRISTOL-MYERS SQUIBB COMPANY (US) | 1996-11-20 | — | — | EP | claimed |
| EP-0743320-A2 | Acyl guanidine and amidine prodrugs | BRISTOL-MYERS SQUIBB COMPANY (US) | 1996-11-20 | — | — | EP | disclosed |